U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H10BrF3N6O
Molecular Weight 427.179
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NS-3623

SMILES

FC(F)(F)C1=CC(NC(=O)NC2=CC=C(Br)C=C2C3=NN=NN3)=CC=C1

InChI

InChIKey=JXPULDIATMTIIN-UHFFFAOYSA-N
InChI=1S/C15H10BrF3N6O/c16-9-4-5-12(11(7-9)13-22-24-25-23-13)21-14(26)20-10-3-1-2-8(6-10)15(17,18)19/h1-7H,(H2,20,21,26)(H,22,23,24,25)

HIDE SMILES / InChI

Molecular Formula C15H10BrF3N6O
Molecular Weight 427.179
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

NS3623 is a human ether-a-go-go (hERG) KV11.1 potassium channel activator. It was shown that treatment of transgenic mouse model of sickle cell disease (SAD mice) with NS3623 improves erythrocyte hydration and diminishes sickling, probably by lowering of the Cl-conductance, which limits salt and concomitant water loss mediated by the Gardós channel, that makes NS3623 antisickling agent in vivo

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
79.4 µM [EC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Patents

Sample Use Guides

SAD mice (transgenic mouse model of sickle cell disease): were treated for 3 weeks with 2 daily administrations of 10, 35, and 100 mg/kg NS3623
Route of Administration: Oral
Application of the hERG agonist NS3623 (10 uM) prolonged the QRS rate dependently. A significant prolongation (16 +/- 6%) was observed at short basic cycle length (BCL 90 ms) but not at longer cycle lengths (BCL 250 ms). The effect could be reversed by the I(Kr) blocker E4031 (1 uM). While partial I(Na) inhibition with flecainide (1 uM) alone prolonged the QRS (34 +/- 3%, BCL 250 ms), the QRS was further prolonged by 19 +/- 2% when NS3623 was added in the presence of flecainide. These data suggest that the effect of NS3623 was dependent on sodium channel availability.
Substance Class Chemical
Created
by admin
on Sat Dec 16 07:53:05 GMT 2023
Edited
by admin
on Sat Dec 16 07:53:05 GMT 2023
Record UNII
J9HB2T5SS4
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NS-3623
Code English
1-(3-TRIFLUOROMETHYLPHENYL)-3-(2-(1H-TETRAZOL-5-YL)-4-BROMOPHENYL)UREA
Systematic Name English
NS 3623
Code English
N-(4-BROMO-2-(1H-TETRAZOL-5-YL)-PHENYL)-N'-(3'-TRIFLUOROMETHYLPHENYL) UREA
Systematic Name English
1-(4-BROMO-2-(2H-TETRAZOL-5-YL)PHENYL)-3-(3-(TRIFLUOROMETHYL)PHENYL)UREA
Systematic Name English
UREA, N-(4-BROMO-2-(2H-TETRAZOL-5-YL)PHENYL)-N'-(3-(TRIFLUOROMETHYL)PHENYL)-
Systematic Name English
N-(4-BROMO-2-(1H-TETRAZOL-5-YL-PHENYL)-N'-(3-(TRIFLUOROMETHYL)PHENYL)-UREA
Systematic Name English
UREA, N-(4-BROMO-2-(1H-TETRAZOL-5-YL)PHENYL)-N'-(3-(TRIFLUOROMETHYL)PHENYL)-
Systematic Name English
Code System Code Type Description
FDA UNII
J9HB2T5SS4
Created by admin on Sat Dec 16 07:53:05 GMT 2023 , Edited by admin on Sat Dec 16 07:53:05 GMT 2023
PRIMARY
CAS
343630-41-1
Created by admin on Sat Dec 16 07:53:05 GMT 2023 , Edited by admin on Sat Dec 16 07:53:05 GMT 2023
PRIMARY
PUBCHEM
9954236
Created by admin on Sat Dec 16 07:53:05 GMT 2023 , Edited by admin on Sat Dec 16 07:53:05 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY